Since Epstein-Barr virus (EBV) infection of Burkitt's lymphoma (BL) cells in vitro reproduces many of the activation effects of EBV infection of primary B lymphocytes, mRNAs induced in BL cells have been cloned and identified by subtractive hybridization. Nine genes encode RNAs which are 4-to >100-fold more abundant after EBV infection. Two of these, the genes for CD21 and vimentin, were previously known to be induced by EBV infection. Five others, the genes for cathepsin H, annexin VI (p68), serglycin proteoglycan core protein, CD44, and the myristylated alanine-rich protein kinase C substrate (MARCKS), are genes which were not previously known to be induced by EBV infection. Two novel genes, EBV-induced genes 1 and 2 (EBI 1 and EBI 2, respectively) can be predicted from their cDNA sequences to encode G protein-coupled peptide receptors. EBI 1 is expressed exclusively in B-and T-lymphocyte cell lines and in lymphoid tissues and is highly homologous to the interleukin 8 receptors. EBI 2 is most closely related to the thrombin receptor. EBI 2 is expressed in B-lymphocyte cell lines and in lymphoid tissues but not in T-lymphocyte cell lines or peripheral blood T lymphocytes. EBI 2 is also expressed at lower levels in a promyelocytic and a histiocytic cell line and in pulmonary tissue. These predicted G protein-coupled peptide receptors are more likely to be mediators of EBV effects on B lymphocytes or of normal lymphocyte functions than are genes previously known to be up-regulated by EBV infection.
in pulmonary tissue. These predicted G protein-coupled peptide receptors are more likely to be mediators of EBV effects on B lymphocytes or of normal lymphocyte functions than are genes previously known to be up-regulated by EBV infection.
Epstein-Barr Virus (EBV) is the cause of infectious mononucleosis, a benign proliferation of infected B lymphocytes (36) , and can also cause acute and rapidly progressive B-lymphoproliferative disease in severely immunocompromised patients or in experimental infection of tamarins (56) . Infection of human B lymphocytes in vitro results in expression of six virus-encoded nuclear proteins (EBNAs) and two virus-encoded membrane proteins (LMPs) (44) and in substantially altered cell growth (61, 62) . EBV-infected B lymphocytes recapitulate features of antigen stimulation in enlarging, increasing RNA synthesis, expressing activation antigens and adhesion molecules, differentiating toward immunoglobulin (Ig) secretion, and proliferating (10, 26, 31, 61, 79, 80) . Unlike antigen-stimulated B lymphocytes, EBVinfected B lymphocytes continue to proliferate in vitro as immortalized lymphoblastoid cell lines (62) .
EBV effects on lymphocytes have been studied by comparing the properties of EBV-negative [EBV(-)] Burkitt's lymphoma (BL) cell lines and EBV-positive [EBV(+)] derivatives, infected by EBV, in vitro (12, 21, 61, (66) (67) (68) . EBV(-) BL cells resemble proliferating centroblasts of germinal centers, characteristically expressing CD10, CD20, CD77 (BLA), class II antigen, and the carbohydrate recognized by peanut agglutinin (12, 21, 23, 28-30, 66, 67 tin, Bac-1, Bcl-2, surface IgD, and CD44 (12, 21, 23, 29, 35, 66, 68, 70, 76, (84) (85) (86) .
Experiments with single-gene transfer into EBV(-) B-lymphoma cells or with specifically mutated EBV recombinants reveal that EBNA 2, LMP 1, and EBNA 3C are essential for lymphocyte growth transformation and alter cellular or viral gene expression. Expression of EBNA 2 alone in EBV(-) BL cell lines results in enhanced transcription of CD23, CD21 (17, 85, 86) , and c-fgr (46) . EBNA 2 also transactivates the LMP promoters (22, 87) . Analysis of a series of EBNA 2 mutants indicates that the ability of EBNA 2 to transactivate gene expression is tightly linked to its essential role in cell growth transformation (16) . LMP 1 is also critical to the effects of EBV on cell growth. LMP 1 transforms immortalized rodent fibroblasts (5, 82, 83) and induces vimentin, Bcl-2, and many of the activation markers and adhesion molecules that EBV induces in BL cells or primary B lymphocytes (8, 35, 84, 85) . In EBV(-) BL cells, EBNA 3c induces higher-level expression of CD21 (85) .
Since altered B-lymphocyte gene expression is a central theme in EBV-induced changes in B-lymphocyte growth, a more complete description of the repertoire of EBV-induced genes would be advantageous before the investigation of specific genes for their role as mediators of EBV effects on cell growth. Genes induced by EBV could also be of importance in B-lymphocyte immunology because of the similar activating and differentiating effects of EBV and antigen. Previously, recognition of such genes has been based largely on increased expression of lymphocyte surface markers (12, 85, 86) , defined by monoclonal antibodies derived against EBV-or antigen-activated B lymphocytes.
Few of these surface markers are likely candidates for important effectors of EBV-or antigen-induced alterations in lymphocyte growth. The experiments described here use subtracted hybridization to identify cDNA clones of RNAs which are more abundant in an in vitro-infected EBV(+) BL cell than in the noninfected EBV(-) control BL cell.
MATERUILS AND METHODS
Cells and cell lines. BL41 and BL30 are EBV(-) BL cell lines. The BLA1/B95-8 and BIL1/P3HR1 cell lines were derived by infecting BL41 with the transforming EBV strain B95-8 or the nontransforming strain P3HR1, respectively (12, 23 a Induction levels were calculated as ratio of signal intensities (BL41/B95-8 to BLA1) for individual probes, divided by the ratio of signal intensities for the P-actin probe.
b The 1.2-kb EBI 1 clone identified on the initial screen was incomplete. Rescreening of the cDNA library resulted in isolation of several additional full-length clones, the largest of which was 2.14 kb.
c Induction of 13-actin RNA was calculated as the ratio of actin signal intensities (BL41/B95-8 to BL41) divided by the ratio of signal intensities for glyceraldehyde phosphate dehydrogenase probe.
Nucleotide sequences of EBV-induced cDNAs. The first 12 clones are described in Table 1 . Ten clones matched seven previously characterized genes: two independent clones each of the genes for complement receptor type 2 (CD21), the serglycin proteoglycan core protein, and vimentin; and one clone each of the genes for cathepsin H, annexin VI (p68), the myristylated alanine-rich protein kinase C substrate (MARCKS), and the lymphocyte hyaluronic acid receptor (CD44). The 2.6-kb MARCKS cDNA precisely matched the previous 1.58-kb human MARCKS cDNA clone (32) at its 5' end (7a). The 3' untranslated region of the new clone is highly homologous to bovine MARCKS cDNA (75) .
The two remaining clones are from novel RNAs, EBVinduced genes 1 (EBI 1) and 2 (EBI 2), whose nucleotide sequences can be predicted to encode G protein-coupled peptide receptors. The complete nucleotide and deduced amino acid sequences of the EBI 1 and EBI 2 cDNAs are shown in Fig. 1A B, respectively. Because the first EBI 1 cDNA was 1.2 kb, significantly shorter than the 2.4-kb RNA, 20 other cDNA clones were obtained by using the initial cDNA as a probe. The largest clone is 2,153 nucleotides (nt) and has a 1,134-nt open reading frame (Fig. 1A ). This clone is probably nearly full length, since it is close to the expected size, considering that it has only a short poly(A) tail. Translation is likely to initiate from either of two AUGs, at nt 64 to 66 or nt 82 to 84, the first of which conforms to a consensus translational initiation sequence (49 codons at nt 34 to 36 and 46 to 48 (Fig. 1B) . Although Fig.  2A) sequence levels. These IL-8 receptors are not expressed on lymphocytes (38, 59) . Excluding the putative EBI 1 signal peptide, the overall amino acid identity among the three proteins exceeds 30%, with conservative changes observed at many of the nonidentical residues. The identity increases to 40% when EBI 1 is compared with either IL-8 receptor individually. Additional similarities with the IL-8 receptors include a high proportion of serine and threonine near the carboxy terminus and a highly acidic amino-terminal extracellular domain. The IL-8 receptor acidic residues are implicated in binding IL-8 basic amino acids (38, 59) .
The EBI 2 gene does not have such a close homolog. EBI 2 has 24% amino acid identity with the thrombin receptor ( Fig. 2B ; data not shown) (81) . Less extensive homologies are observed with a number of other G protein-coupled receptors, including the receptors for vasoactive intestinal polypeptide, somatostatin (type 1), and angiotensin II, as well as with the low-affinity IL-8 receptor (Fig. 2B) Analysis of induced gene expression by RNA blot hybridization. Probes from seven of the nine EBV-induced cDNAs (vimentin and CD21 were previously shown to be EBV induced and were not further evaluated) were hybridized to identical blots of polyadenylated RNA from the EBV(+) or EBV(-) BIA1 cell lines or from the EBV-transformed lymphoblastoid cell line IB4 (Fig. 3) . The RNAs loaded in the EBV(+) BL41 and EBV(-) BL41 lanes were standardized with respect to 3-actin reactivity. Significantly less IB4 cell RNA was used because of the high abundance of the putative induced-gene RNAs in these cells (Fig. 3, actin  probe) . Probes from each of the cDNA clones detected RNAs which are significantly more abundant in both IB4 and EBV(+) BL41 cells than in EBV(-) BL41 cells. Induction factors indicated in Table 1 (Fig. 4) . EBI 1 and EBI 2 RNAs are abundant in primary human lymphocytes transformed by EBV in vitro and propagated as continuous lymphoblastoid cell lines for several years (IB4) or for less than 1 year (LCL-W91) (Fig. 4) . EBI 1 RNA is faintly detectable in the human T-cell line Jurkat and is abundantly expressed in a second T-cell line, HSB-2 (Fig. 4) . EBI 2 RNA is not detected in either of these T-cell lines (Fig. 4) or in a third T-cell line, Molt-4 (data not shown). EBI 1 is not expressed in the human promyelocytic line HL60, the chronic myelogeneous leukemia cell line K562, the epithelial cell line RHEK-1, the fibroblast-like osteosarcoma cell line TK143, or the monocytic cell line U937 (Fig. 4) . EBI 2, however, is expressed weakly, relative to actin, in HL60, U937 (U937 RNA is partially degraded), and HeLa ( Fig. 4 ; data not shown) cells. EBI 1 and EBI 2 RNAs are abundant in human spleen tissue, somewhat less abundant relative to actin in tonsil tissue, and undetectable in bone marrow (Fig. 4) . Both genes were expressed in resting PBMCs at levels comparable to those in IB4 or LCL-W91 B lymphoblastoid cells (Fig. 4) . Expression increased in parallel cultures stimulated for 72 h with pokeweed mitogen, although actin expression also increased after pokeweed mitogen treatment (Fig. 4) . The EBI 1 and EBI 2 RNA in stimulated and nonstimulated PBMC cultures is likely to be mostly in B lymphocytes since EBI 1 RNA is present at low levels and EBI 2 RNA is absent in phytohemagglutinin-stimulated, PBMC-derived T lymphocytes (Fig. 4) . These findings are consistent with the expression patterns observed in T-cell lines. EBI 1 and EBI 2 RNA levels in a variety of nonhematopoietic human tissues were also evaluated. The EBI 1 probe detects small amounts of RNA in both lung and pancreas tissues (Fig. 5) . Rehybridization of this blot with an Ig mu VOL. 67, 1993 on October 29, 2017 by guest
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.ilt' PBMC is unfractionated peripheral blood mononuclear cells; PBMC PWM is PBMC stimulated for 72 h with pokeweed mitogen (2.5 pug/rml); PBT PHA is T cells purified from PBMC by sheep erythrocyte rosetting, stimulated for 72 h with phytogemagglutinin (1 ug/rml); B MARR is postmortem bone marrow; SPLEEN is unfractionated cells from surgically excised spleen; HL60 is a promyelocytic leukemia cell line; U937 is a monocytic leukemia cell line; K562 is a chronic myelogenous leukemia cell line; JURKAT is a T-cell leukemia cell line; HSB-2 is a T-cell acute lymphoblastic leukemia cell line; RHEK-1 is an adenovirus-simian virus 40-transformed human keratinocyte; TK143 is a osteosarcoma cell line. Each panel is a composite prepared from autoradiographs of two separate blots for each probe. chain probe (Fig. 5 , Ig ,u probe) indicated that these tissue preparations contained significant amounts of Ig RNA, probably because of the presence of B lymphocytes in the tissues. Since EBI 1 RNA is abundant in peripheral blood lymphocytes, the EBI 1 RNA in the lung and pancreas tissues is likely to be due to B lymphocytes. Similarly, the low level of EBI 2 RNA detected in pancreas tissue is probably due to infiltrating B lymphocytes (Fig. 5) . However, the abundance of EBI 2 RNA in lung tissue is too great to attribute to lymphocyte contamination and is more likely to be due to specific expression in pulmonary epithelial cells or macrophages (Fig. 5) .
DISCUSSION
The present studies were undertaken to elucidate the mechanisms of EBV transformation of B lymphocytes by identifying cell genes whose expression is increased by EBV infection. By identifying genes induced in EBV(+) versus EBV(-) BL cells, the effects of EBV infection were observed in human B lymphocytes, the natural target of EBV infection and growth transformation. Differences in gene expression that were not due to EBV infection were mini- This report describes the identification of nine EBVinduced genes, CD21 and vimentin genes being the only two which were previously known to be EBV induced (8, 12) .
CD21 is the EBV receptor, and CD21 mRNA is induced within 36 h following in vitro infection or antigen stimulation of normal peripheral blood B cells (2, 72) . EBV induction of CD21 may be a consequence of activating and differentiating effects. Gene transfer experiments in EBV(-) BL cells indicate that CD21 expression is increased by EBNA 2 or EBNA 3C expression (17, 85, 86) . CD21 is also the receptor (CR2) for the C3d fragment of complement (88) , associates with Ig in the B lymphocyte plasma membrane (77) , and may mediate the stimulating effects of antigen-antibody and complement complexes on uninfected B lymphocytes (53 (39, 40) . Steady-state MARCKS RNA levels may be regulated in part by mRNA stability (11) . The unusually high degree of homology among three prime untranslated regions of the human and bovine MARCKS RNAs (75) suggests that these sequences may play a regulatory role, possibly in mRNA stability. Although its function is unknown, MARCKS pro-tein localizes to substratum contact points in macrophages in physical association with vinculin, talin, and cytoskeletal actin (65, 78) . MARCKS protein also binds to calmodulin with high affinity and inhibits calmodulin-mediated activation of phosphodiesterase (27, 55) . This interaction is disrupted by protein kinase C-mediated MARCKS phosphorylation. MARCKS-regulated interaction with calmodulin is of particular interest in light of the role of calmodulin in lymphocyte apoptosis (54) and the ability of EBV or LMP 1 to protect cells from apoptosis (35) . MARCKS may be a mediator of the anti-apoptotic effects of EBV infection. Annexin VI is a Ca2' binding protein of the lipocortin family (18) and is phosphorylated in response to growth factor stimulation (43) . It may associate with CD21 (6). In vitro membrane reconstitution studies indicate that annexin VI may regulate the release of Ca2+ from intracellular stores (34) . Annexin VI is expressed only in mantle zone B cells and is not detectable in GC cells (15) .
Recent experiments indicate that annexin VI plays a critical role in the formation and budding of clathrin-coated pits by a process which may be triggered by specific phosphorylation (51) . These findings are of particular significance since cathepsin H and serglycin may also be intracellular vesicle constituents. Cathepsin H is a lysosomal cysteine protease (9) , whereas serglycin is a core protein of proteoglycans. Although not previously known to be expressed in lymphocytes, serglycin is stored in granulocyte secretory granules, where it may neutralize hydrolytic enzymes (45, 47) .
CD44 binds hyaluronic acid (4) and is the lymphocyte homing receptor for high endothelial venules. Its expression increases following anti-Ig stimulation of murine B cells (13) . In contrast with other EBV-induced genes, high-level CD44 expression in vivo is observed primarily in germinal-center B lymphocytes (24) . CD44 may associate with the lymphocyte cytoskeleton via an ankyrinlike molecule (42) . Transfection studies with Daudi and BL41 cell lines indicate that LMP 1 is responsible for CD44 induction (85) .
The most significant outcome of this study is the discovery of the first G protein-coupled peptide receptors expressed in lymphocytes exclusively ( Homologies between EBI 1 and the high-and low-affinity IL-8 receptors are particularly striking and are apparent at both the nucleotide and amino acid levels. In fact, EBI 1 is the closest known homolog of the IL-8 receptors. The neuropeptide Y receptor type 2, for which only the bovine form has thus far been cloned, also exhibits a high degree of homology to these proteins (64) . These four proteins appear to constitute a closely related subfamily within the superfamily of G protein-coupled receptors. EBI 2 exhibits more distant homology to these proteins and appears to be most closely related to the thrombin receptor.
We have identified a previously unrecognized, highly conserved G protein-coupled receptor motif at the junction of the third transmembrane domain and second intracellular loop. This motif, (A/S)-(I/V)-D-R-(Y/F)-X-X-X-X, where X represents hydrophobic residues, is characteristic of even distantly related G protein-coupled receptors, including photoreceptor opsins and receptors from phylogenetically divergent species such as Drosophila species. The motif is not present in other proteins. The restricted presence of this sequence in G protein-coupled receptors is most consistent with an important role in G protein-coupled receptor function. This region is implicated in receptor interaction with G proteins (48) . The sequence includes five continuous hydrophobic amino acids, and ligand binding may alter the disposition of the hydrophobic portion of this sequence with respect to the adjacent plasma membrane, effecting changes which modulate G protein interaction.
Ligands for EBI 1 or EBI 2 are likely to be polypeptide cytokines since EBI 1 and EBI 2 are most closely related to G protein-coupled receptors which have polypeptide ligands. Further, a third transmembrane domain aspartate residue is highly conserved among G protein-coupled biogenic amine receptors but is absent from EBI 1 and EBI 2, excluding membership in that family (73) . The close similarity between EBI 1 and the IL-8 receptors is evidence that the EBI 1 ligand is a polypeptide proinflammatory "intercrine" factor similar to ACI-2, GRO/MGSA or RANTES, or IL-8 (63) .
The expected action of EBI 1 and EBI 2 is through G proteins and secondary messenger pathways by the activation of effector molecules such as adenyl cyclase, cyclic AMP phosphodiesterase, phospholipase C, or various ion VOL. 67, 1993 on October 29, 2017 by guest http://jvi.asm.org/ Downloaded from channels (20 (69) .
The finding that EBV induces these two putative G protein-coupled peptide receptors is also of interest in light of the recent findings that human cytomegalovirus and herpesvirus saimiri have incorporated homologs to G protein-coupled receptors into their genomes (60) . Cytomegalovirus has three such genes (14) . This virus is unusual among herpesviruses in its transient stimulation of cell DNA synthesis early in lytic replication and in establishing infection in precursor cells in bone marrow (52 (Fig. 2B ).
The identification of 9 different EBV-induced mRNAs among the first 12 
